Oculomics and oculometrics: Using the eye as a biomarker for neurodegenerative disease
January 25th 2024Oculomics and oculometrics are part of an emerging field that looks at using the eye and eye movements as a biomarker for systemic and neurologic health. This article will review some of the recent findings correlating ocular structures and eye movement function with neurologic and cerebrovascular disease and discuss the future of eye care in the neurologic space.
Diplopia in concussion – what is normal? What is abnormal, and when should it go away?
January 15th 2024New developments to progress diagnostic criteria for Mild Traumatic Brain Injury (TBI) are discussed by The Mild Traumatic Brain Injury (TBI) Task Force of the American Congress of Rehabilitation Medicine Brain Injury Special Interest Group.